6550--Micro Reagents and Service Contract
ID: 36C25726Q0052Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF257-NETWORK CONTRACT OFFICE 17 (36C257)San Antonio, TX, 78240, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Veterans Affairs (VA) intends to award a sole source Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Becton, Dickinson and Company for the procurement of Micro Reagents and Service Maintenance for the Central Texas Health Care System in Temple, Texas. This contract, identified by solicitation number 36C25726Q0052, will cover a five-year ordering period from January 1, 2026, to December 31, 2030, and is essential for maintaining the specialized supplies and equipment used in the Pathology and Laboratory Department. Interested parties who believe they can meet the requirements are invited to submit supporting evidence, including an OEM authorization letter, to Contract Specialist Teresa Arzola at Teresa.Arzola@va.gov by October 29, 2025, at 9:00 AM CST. This notice is not a request for competitive quotations, and the VA has determined that only Becton, Dickinson and Company can fulfill the contract requirements due to the unique nature of the services and products needed.

    Point(s) of Contact
    Teresa ArzolaContract Specialist
    (210) 740-3729
    Teresa.Arzola@va.gov
    Files
    Title
    Posted
    The Department of Veterans Affairs (VA) Network Contracting Office 17 intends to award a sole source, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Becton, Dickinson and Company for Micro Reagents and Service Maintenance. This contract, solicited under number 36C25726Q0052, is for the Central Texas Health Care System in Temple, Texas, and covers a five-year ordering period from January 1, 2026, to December 31, 2030. The VA determined that Becton, Dickinson and Company is the only responsible source capable of providing the required reagents and service plans due to the specialized nature of the supplies and equipment. This notice is not a request for competitive quotations; however, interested parties believing they can fulfill the requirement are invited to submit supporting evidence, including an OEM authorization letter, to Contract Specialist Teresa Arzola by October 29, 2025.
    Lifecycle
    Title
    Type
    Special Notice
    Similar Opportunities
    J066--New - VISN 17 GeneXpert Analyzer M&R Consolidated IDIQ
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source, firm-fixed-price, single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Cepheid for the maintenance and repair services of GeneXpert analyzers. This procurement includes service agreements for various GeneXpert systems, along with necessary modules and reagents, to support the Pathology and Laboratory Medicine Service (P&LMS) across multiple locations within Veterans Integrated Service Network (VISN) 17, including El Paso, South Texas, Central Texas, Big Spring, and Amarillo VA Healthcare Systems. The GeneXpert systems are critical for laboratory diagnostics, ensuring timely and accurate results for veterans' healthcare needs. Interested parties may submit capability statements to the primary contact, Delphia Schoenfeld, at delphia.schoenfeld@va.gov within 10 calendar days of this notice, as the contract will be awarded to Cepheid if no other responsible sources are identified.
    6515--Special Notice 5-10 Dec 2025 Roche diagnostic supplies
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, intends to negotiate a sole-source, firm-fixed-price contract with Roche Diagnostic Corporation for the provision of ImmunoHistoChemical (IHC) and Special Stain (SS) reagents necessary for diagnostic staining at the Overton Brooks VA Medical Center in Shreveport, LA. This procurement includes not only the reagents but also compatible instrumentation, installation, staff training, and ongoing technical support to ensure uninterrupted diagnostic capabilities over a base period plus four option years. The goods and services are critical for the Pathology and Laboratory Medicine Service, as Roche Diagnostic Corporation is the sole manufacturer of the required VENTANA instrumentation and reagents. Responses to this opportunity are due by December 10, 2025, at 10:00 AM CST, with all inquiries to be submitted by December 8, 2025, at 10:00 AM CST; interested parties may contact Contract Specialist Rhonda Gibson at rhonda.gibson2@va.gov or by phone at 832-352-2915 for further information.
    6550--HEMOCHRON SIGNATURE ELITE REAGENTS BASE PLUS 4 OPTION YEARS
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hemochron Signature Elite Reagents, with a contract that includes a base year and four option years, extending from January 1, 2026, to December 31, 2030. The Southern Arizona VA Health Care System requires these reagents for quality control materials, supplies, and consumables compatible with existing Hemochron Signature Elite Instruments, all of which must be FDA-approved and delivered within specified timeframes. This procurement is critical for maintaining the efficiency and accuracy of patient testing at the Tucson facility. Interested vendors must submit their quotations electronically to Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov by December 9, 2025, and are encouraged to address any questions by November 28, 2025.
    Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.
    Buyer not available
    The Department of Veterans Affairs is seeking a contractor to provide the distribution of BioRad BioPlex laboratory reagents for the Seattle VA Medical Center. The procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for automated immunoassay instrumentation capable of performing a variety of diagnostic tests, including those for autoimmune diseases and infectious agents. These reagents and instruments are critical for enhancing laboratory capabilities in diagnosing and managing patient care within the VA system. Interested small businesses must submit their quotes by December 19, 2025, at 17:00 Pacific Time, and can direct inquiries to Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632.
    J066--NEW – Base Plus 1 Option Yrs – BioMerieux Biofire Service
    Buyer not available
    The Department of Veterans Affairs, Network Contracting Office 17, intends to award a sole source, firm-fixed-price contract to bioMérieux, Inc. for a full-service maintenance agreement covering three Government-owned BioFire FilmArray instruments located at the South Texas Veterans Health Care System. The contract will include a base year and one option year, with services provided exclusively by a BioFire Certified Diagnostic Service Engineer, encompassing all labor, travel, replacement parts, software, and related expenses necessary to maintain the instruments in optimal operating condition and compliance with regulatory requirements. These instruments are critical for laboratory diagnostics, and the government has determined that bioMérieux is the only source capable of providing the required certified service. Interested parties may submit capability statements within seven calendar days of this notice, and for further inquiries, contact Ognian D. Ivanov at 210-694-6302 or via email at ognian.ivanov@va.gov.
    6505--Blood Products IDIQ for SFVAHCS
    Buyer not available
    The Department of Veterans Affairs, through Network Contracting Office 23, is seeking proposals for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract for blood products and necessary testing services for the Sioux Falls VA Healthcare System. The contract will cover a base period from February 1, 2026, to September 30, 2026, with five optional ordering periods extending through January 31, 2031, and has a maximum lifetime value of $1,000,000.00, with a guaranteed minimum of $30,000.00. This procurement is critical for ensuring the availability of safe and compliant blood products, adhering to FDA and AABB standards, and includes requirements for volunteer donor blood and specific turnaround times for testing. Interested offerors must submit their proposals electronically by December 12, 2025, and direct any questions to Senior Contracting Officer Joshua I. Imdacha at joshua.imdacha@va.gov.
    Q301--NEW - NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQ
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQ, aimed at providing laboratory testing services for the VA North Texas Healthcare System in Dallas, Texas. The contract will cover a range of services including tissue biopsies, surgical pathology, flow cytometry, and genetic analyses, with a performance period from April 1, 2026, to March 31, 2031, and four option years. This procurement is crucial for ensuring timely and accurate medical testing for veterans, with specific requirements including CLIA accreditation, HIPAA compliance, and secure electronic reporting. Interested vendors must submit their proposals by December 15, 2025, at 3:00 PM Eastern Time, and can direct inquiries to Contracting Officer Delphia Schoenfeld at delphia.schoenfeld@va.gov.
    J065--Bayer Medrad Injectors Full Service
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source Firm-Fixed-Price Contract to Novamed Corporation for the full service of Bayer Medrad Injectors. This contract, identified as 36C25724P0085, will provide essential services including onsite support by a Bayer certified field engineer, hardware system coverage, calibration, software updates, EPM certified part replacements, and comprehensive inspection and safety testing for various Bayer/Medrad models at the Dallas VA Medical Center. The procurement is being conducted under FAR 13.5, indicating the intent to negotiate with a single source due to the specialized nature of the services required. Interested parties may submit their capability information by December 12, 2025, at 10:00 A.M. CT, to Rafael Rodriguez at Rafael.Rodriguez2@va.gov, as the government may consider competitive procurement based on the responses received.
    6550--Triage Meterpro Reagents
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified sources to provide QuidelOrtho Triage MeterPro Reagents for the New Mexico VA Healthcare System, through a Sources Sought Notice (RFI 36C26226Q0177). The procurement aims to acquire various medical diagnostic and drug testing supplies, including Triage Tox DS Panels, Controls, and BNP Test Kits, which are essential for accurate drug testing and patient care. Interested vendors are encouraged to submit their capabilities, pricing, and relevant business information by December 8, 2025, at 10:00 a.m. PST, to the Contract Specialist, Clift Domen, at Clift.Domen@va.gov.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.